ConquerFear-Group: A Psychological Intervention for Fear of Cancer Recurrence (NCT04137575) | Clinical Trial Compass
CompletedNot Applicable
ConquerFear-Group: A Psychological Intervention for Fear of Cancer Recurrence
Denmark85 participantsStarted 2019-10-21
Plain-language summary
The primary aim of this randomized controlled trial is to evaluate the effect of ConquerFear-Group (CF-G), compared with a control condition (CC), on Fear of Cancer Recurrence (FCR). Secondary aims are to explore the effect of CF-G on emotion regulation and additional psychological outcomes, and to explore mediating effects of emotion regulation, metacognitions, working alliance, patient adherence, and group cohesion. In addition, treatment expectancy, participation in other treatments after completion of the intervention of the study and demographic and clinical variables will be explored as moderators.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Eligible patients have a confirmed past diagnosis of stage 1-3 breast cancer,
✓. have been treated with curative intent,
✓. have completed all hospital-based adjuvant treatments 3 months to 5 years prior to study entry,
✓. are disease free,
✓. scores in the clinical range (≥22) on the Short Form of the Fear of Cancer Recurrence Inventory (FCRI-SF),
✓. are able to read and write Danish,
✓. are over the age of 18 years, and
✓. are able to give informed consent.
Exclusion criteria
✕. self-reported current major depression,
✕. currently receiving psychological treatment from a therapist not involved in the study,
✕
What they're measuring
1
Fear of cancer recurrence
Timeframe: Baseline, 1, 2, 3, 4, 5, and 6 weeks after baseline, 1 week post intervention, 3- and 6-months follow-up